Vergleich

Recombinant SARS-CoV-2 S1 Subunit Protein RBD, R346K/E484K/N501Y mutant

Hersteller Raybiotech
Kategorie
Typ Proteins Recombinant
Specific against other
Format Liquid
Applikationen WB, IP, ELISA, Dot
Menge 500 ug
ArtNr 230-30213-500
Konjugat/Tag His
eClass 6.1 34160400
eClass 9.0 42020190
Lieferbar
Purity >95% - SDS-PAGE under reducing conditions and visualized by Coomassie blue staining
Application Information
Functional Assay, Protein-protein Interaction, Post-translational Modifications, ELISA, EIA, Western Blotting, Dot Blotting, Immunoprecipitation, Protein Array, etc.
Storage/Stability
Upon arrival, the protein may be stored for 2 weeks at 4 °C. For long term storage, it is recommended to store at -20 °C or -80 °C in appropriate aliquots. Avoid repeated freeze-thaw cycles.
Formulation
Supplied as a 0.2 um filtered solution in PBS (pH 7.4)
Expressed Region
Arg319-Phe541. R346K/E484K/N501Y mutant: amino acid Arg (R) at 346 position was mutated to Lys (K), Glu (E) at 484 position was mutated to Lys (K), Asn (N) at 501 position was mutated to Tyr (Y).
Protein Name & Synonyms
Spike protein, S Protein, S1 Subunit, Host Cell Receptor Binding Domain (RBD)
Expression System
Human embryonic kidney 293 (HEK293) cells
Purification
His-tag affinity purification by immobilized metal ion affinity chromatography (IMAC)
Concentration (lot specific)
Lot specific (see the label on the vial), determined by BCA protein assay
Endotoxin Level
< 0.5 EU per µg of the protein as determined by the LAL method
Conjugation/Tag Notes
C-terminal his-tag
Molecular Weight (kDa)
Recombinant protein product has a calculated molecular mass of ∼25 kDa. Due to the abundant glycosylation, it migrates as approximately ∼30 kDa protein bands in SDS-PAGE under DTT, beta-mercaptoethanol reducing conditions. After deglycosylation under native and denature conditions, the protein presented as one reduced ∼25 kDa band.
SDS-PAGE Image
Figure 1. Deglycosylation analysis of purified recombinant proteins. The same amount of purified proteins were untreated (Lane 2) or treated with protein deglycosylation enzymes under native (Lane 3) or reducing (Lane 4) conditions. Deglycosylation treatment resulted in a mobility shift of the protein to produce one reduced band at the expected size, thus indicating that the untreated recombinant protein (Lane 2) was glycosylated. Lane 1: Protein standard ladder (kDa). Lane 2: Untreated protein Lane 3: Treated protein with deglycosylation enzymes under native conditions. Lane 4: Treated protein with deglycosylation enzymes under reducing conditions.
Shipping
Ice packs
Custom Labeling Request
We can custom label this protein with biotin or fluorescent dyes (choose from violet, blue, green or red). Request now.
Binding Function
Product binding ability was measured by ELISA. The immobilized recombinant human ACE2 protein (Catalog #230-30165, coated at 0.5 ug/ml, 100 ul/well) was incubated with the serial diluted SARS CoV-2 S1 RBD R346K/E484K/N501Y mutant protein (Catalog #230-30213). The bound mutant protein was detected by mouse anti-S1 RBD monoclonal antibody using ELISA. The calculated EC50 is 39.48 ng/ml.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 500 ug
Lieferbar: In stock
lieferbar

Lieferung vsl. bis 02.08.2024 

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen